-- Completed patient enrollment in Phase III ADVOCATE trial of avacopan in ANCA-associated vasculitis ...
CHICAGO, Feb. 26, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider ...
Merger Expected to Close in January 2019SAN DIEGO, Jan. 15, 2019 (GLOBE NEWSWIRE) -- ...
